Core Laboratories Inc. DE (CLB)
2025-06-30 | 2025-03-31 | 2024-09-30 | ||
---|---|---|---|---|
Revenue | 130,159 | 123,585 | 134,397 | |
Other (income) expense, net | 2,967 | -2,335 | 4,529 | |
Depreciation | 3,561 | 3,593 | 3,551 | |
Cost of services and product sales exclusive of depreciation expense shown below-Service | 74,053 | - | - | |
Cost of services and product sales exclusive of depreciation expense shown below-Product | 29,648 | - | - | |
Amortization | 109 | 124 | 125 | |
General and administrative expense, exclusive of depreciation expense shown below | 10,464 | 13,647 | 8,642 | |
Cost of services and product sales exclusive of depreciation expense shown below | - | 99,469 | 106,805 | |
Operating income | 15,291 | 4,417 | 19,803 | |
Interest expense | 2,711 | 2,602 | 3,108 | |
Income before income taxes | 12,580 | 1,815 | 16,695 | |
Income tax expense | 1,911 | 1,746 | 4,691 | |
Net income | 10,669 | 69 | 12,004 | |
Net income attributable to non-controlling interest | 33 | 223 | 259 | |
Net income attributable to core laboratories inc | 10,636 | -154 | 11,745 | |
Basic earnings (loss) per share attributable to core laboratories n.v | 0.23 | - | 0.25 | |
Earnings per share, diluted | 0.22 | - | 0.25 | |
Weighted average number of shares outstanding, basic | 46,632,000 | 46,773,000 | 46,922,000 | |
Weighted average number of shares outstanding, diluted | 47,364,000 | 46,773,000 | 47,820,000 |